Summary & Overview
CPT 12020: Simple Closure for Superficial Wound Dehiscence
Headline: CPT 12020: Simple Closure for Superficial Wound Dehiscence
Lead: CPT 12020 designates a straightforward surgical repair for superficial wound dehiscence using simple closure techniques. The code is relevant across outpatient and office settings and is commonly encountered in post-surgical wound management.
What the code represents and why it matters nationally: CPT 12020 captures the clinical service of closing superficial dehisced wounds—procedures that affect post-operative recovery, infection risk, and patient comfort. As a common, low-complexity integumentary procedure, proper coding ensures accurate clinical documentation and appropriate claims processing across payers.
Key payers covered: This analysis considers coverage patterns and billing practice implications for Aetna, Blue Cross Blue Shield, Cigna Health, Medicare, and UnitedHealthcare.
Overview of what readers will learn: Readers will find a concise explanation of the procedure’s clinical scope, typical sites of service, and how the code is positioned relative to more extensive secondary closure codes. The publication highlights common documentation elements, payer considerations, and coding relationships relevant to surgical repair of superficial wounds. It also notes when additional codes or different code selections may be appropriate for more extensive or complicated closures.
Context and limits: Where specific payment or policy details are not provided in the input, the publication indicates "Data not available in the input."
CPT Code Overview
CPT 12020 describes the treatment of superficial wound dehiscence with simple closure. This procedure falls under the Surgical Repair (Integumentary System) service type and involves techniques used to close a wound that has partially opened along a surgical incision or superficial skin disruption.
Typical sites of service for CPT 12020 include the office (POS 11) and outpatient surgical settings, where providers perform straightforward, low-complexity closures of superficial tissue layers. The code applies to simple closure methods rather than extensive or complex secondary repair.
Clinical & Coding Specifications
Clinical Context
A 45-year-old patient presents to an outpatient clinic 10 days after an abdominal surgery with separation of the superficial incision edges and serous drainage without deep tissue involvement. The clinician evaluates the wound, performs local anesthesia, irrigates the area, debrides minimal necrotic tissue if present, and performs a simple layered or interrupted closure of the superficial wound edges in the office setting. The workflow includes pre-procedure consent, wound assessment, procedure documentation of technique and materials, wound closure with suture, post-procedure wound care instructions, and a follow-up visit to assess healing.
Coding Specifications
-
Modifiers:
-
58: Staged or Related Procedure or Service by the Same Physician During the Postoperative Period — used when the wound closure is planned as a staged or related procedure during the global period of a prior surgery. -
78: Unplanned Return to the Operating/Procedure Room by the Same Physician Following Initial Procedure for a Related Procedure During the Postoperative Period — used when the patient requires an unplanned return to the operating or procedure room for a related procedure during the global period. -
Provider Taxonomies:
| Taxonomy Code | Specialty |
|---|---|
208600000X | Surgery Physician |
208800000X | Plastic Surgery Physician |
207Q00000X | Family Medicine Physician |
Related Diagnoses
-
T81.31XA— Disruption of external operation (surgical) wound, not elsewhere classified, initial encounterRelevance: Identifies superficial postoperative wound dehiscence appropriate for simple closure such as
12020. -
T81.32XA— Disruption of internal operation (surgical) wound, not elsewhere classified, initial encounterRelevance: Indicates internal wound disruption; may be present concurrently but typically requires evaluation to determine suitability of superficial closure.
-
L98.3— Eosinophilic cellulitis [Wells]Relevance: A dermatologic condition that can cause skin breakdown or lesions potentially requiring wound management; relevant when wound appearance or diagnosis influences closure approach.
-
L98.8— Other specified disorders of skin and subcutaneous tissueRelevance: Captures specified noninfectious or other skin disorders that may complicate wound healing and be documented as the underlying diagnosis for closure.
-
S01.81XA— Laceration without foreign body of other part of head, initial encounterRelevance: Represents a traumatic superficial laceration that may be repaired with a simple closure similar to the technique described by
12020.
Related CPT Codes
| CPT Code | Description |
|---|---|
13160 | Secondary closure of surgical wound or dehiscence, extensive or complicated |
13160 represents a more extensive or complicated secondary closure compared with a simple closure. In clinical workflow, 13160 may be used as an alternative when the wound dehiscence is extensive or involves complicated repair beyond a simple superficial closure. 13160 may be performed instead of 12020 when complexity, tissue loss, or scar revision is required. 13160 is not additive to 12020 and should be selected based on the documented complexity of the repair.
National Reimbursement Benchmarks
National mean rates for CPT 12020 place Medicare ($327.42) between the BUCA average commercial benchmark ($312.27) and higher commercial payers such as UnitedHealth Group ($432.55) and Cigna ($401.06). BUCA’s mean is slightly below Medicare while several commercial payers have materially higher mean allowed rates.
Rate dispersion, measured as the difference between the 75th and 25th percentiles, is widest for UnitedHealth Group (525.33 - 268.00 = $257.33) and Cigna (487.00 - 257.00 = $230.00), indicating broader variability among allowed rates. The tightest distributions are Medicare (340.00 - 306.00 = $34.00) and Aetna (250.00 - 149.69 = $100.31), with Medicare notably more compressed than commercial payers. The table and chart below present the full breakdown of mean rates and percentiles by payer.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.